COSENTYX Rx

Select the drug indication to add to your list

COSENTYX

Arthritis/rheumatic disorders
Psoriasis
Only 4 drugs may be compared at once

Generic Name and Formulations:

Secukinumab 150mg/mL; soln for SC inj; and lyophilized pwd for SC inj after reconstitution; preservative-free.

Select therapeutic use:

Indications for COSENTYX:

Active psoriatic arthritis or ankylosing spondylitis in adults.

Adult:

Rotate inj site (eg, upper arms, thighs, or any quadrant of abdomen). ≥18yrs: Psoriatic arthritis with coexistent plaque psoriasis: 300mg (given as two 150mg SC injections) at Weeks 0, 1, 2, 3, and 4 then 300mg every 4 weeks. Other psoriatic arthritis (with a loading dose): 150mg by SC inj at Weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter; (without a loading dose): 150mg every 4 weeks; consider a 300mg dose if psoriatic arthritis continues. Cosentyx may be administered with or without MTX. Ankylosing spondylitis (with a loading dose): 150mg by SC inj at Weeks 0, 1, 2, 3, and 4 and every 4 weeks thereafter; (without a loading dose): 150mg every 4 weeks.

Children:

<18yrs: not evaluated.

Warnings/Precautions:

Increased risk of infections. Chronic or history of recurrent infection. If a serious infection develops, monitor closely and discontinue until resolves. Evaluate for TB infection prior to initiating; monitor for active TB during and after therapy. Patients with active TB infection: do not start. History of latent or active TB; consider anti-TB therapy prior to initiation. Inflammatory bowel disease; monitor. Discontinue if anaphylaxis or serious allergic reactions occur. Latex allergy (Sensoready pen and prefilled syringe only). Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant live vaccines: not recommended. Non-live vaccines: may get suboptimal response. Concomitant CYP450 substrates with a narrow therapeutic index (eg, warfarin, cyclosporine); monitor and consider adjusting dose.

Pharmacological Class:

Interleukin-17A antagonist.

Adverse Reactions:

Nasopharyngitis, diarrhea, upper respiratory tract infection, rhinitis, oral herpes, pharyngitis, urticaria, rhinorrhea; inflammatory bowel disease, hypersensitivity reactions, other serious infections.

Generic Availability:

NO

How Supplied:

Single-use Sensoready pen—1, 2; Single-use prefilled syringe—1, 2; Single-use vial—1

COSENTYX 2 sensoready pens of 150mg/ml cartons (Qty:2)

appx. price $9034.00

Indications for COSENTYX:

Moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Adult:

Rotate inj site (eg, upper arms, thighs, or any quadrant of abdomen). ≥18yrs: 300mg (given as two 150mg SC injections) at Weeks 0, 1, 2, 3, and 4 then 300mg every 4 weeks. For some patients, 150mg dose may be acceptable.

Children:

<18yrs: not evaluated.

Warnings/Precautions:

Increased risk of infections. Chronic or history of recurrent infection. If a serious infection develops, monitor closely and discontinue until resolves. Evaluate for TB infection prior to initiating; monitor for active TB during and after therapy. Patients with active TB infection: do not start. History of latent or active TB; consider anti-TB therapy prior to initiation. Inflammatory bowel disease; monitor. Discontinue if anaphylaxis or serious allergic reactions occur. Latex allergy (Sensoready pen and prefilled syringe only). Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant live vaccines: not recommended. Non-live vaccines: may get suboptimal response. Concomitant CYP450 substrates with a narrow therapeutic index (eg, warfarin, cyclosporine); monitor and consider adjusting dose.

Pharmacological Class:

Interleukin-17A antagonist.

Adverse Reactions:

Nasopharyngitis, diarrhea, upper respiratory tract infection, rhinitis, oral herpes, pharyngitis, urticaria, rhinorrhea; inflammatory bowel disease, hypersensitivity reactions, other serious infections.

Generic Availability:

NO

How Supplied:

Single-use Sensoready pen—1, 2; Single-use prefilled syringe—1, 2; Single-use vial—1

COSENTYX 2 sensoready pens of 150mg/ml cartons (Qty:2)

appx. price $9034.00